Related Experiment Video
Updated: May 26, 2026
09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Developing a vaccine against multiple psychoactive targets: a case study of heroin
G Neilm Stowe1, Joel E Schlosburg, Leandro F Vendruscolo
1Departments of Chemistry and Immunology, The Skaggs Institute for Chemical Biology and Worm Institute of Research and Medicine (WIRM), The Scripps Research Institute, La Jolla, California 92037, USA.
CNS & Neurological Disorders Drug Targets
|January 11, 2012
Summary
Developing a heroin addiction vaccine is crucial. This review explores strategies for creating an effective vaccine by focusing on immunogenicity and specificity to block heroin
Area of Science:
- Pharmacology
- Immunology
- Addiction Medicine
Background:
- Heroin addiction poses significant social and health challenges.
- Current medications for heroin addiction have limitations, including side effects and relapse potential.
- A vaccine offers a potential adjunct therapy to block heroin's effects, avoiding current treatment drawbacks.
Purpose of the Study:
- To review strategies for designing a vaccine against heroin addiction.
- To discuss challenges in targeting heroin due to its metabolism and psychoactive metabolites.
- To explore hapten design and immunoconjugate strategies for vaccine development.
Main Methods:
- Review of opiate scaffolding and hapten design principles for immunogenicity.
- Analysis of strategies to ensure specificity against heroin and its metabolites.
- Examination of immunoconjugate approaches for vaccine formulation.
Main Results:
- Heroin presents a complex vaccine target due to its metabolism into multiple psychoactive compounds.
- Designing immunogens requires careful consideration of opiate structure and hapten modification.
- Achieving specific immune responses to block heroin's central nervous system effects is challenging but feasible.
Conclusions:
- Vaccine-based therapy is a promising avenue for heroin addiction treatment.
- Successful vaccine development hinges on overcoming challenges related to heroin's pharmacokinetics and metabolism.
- Further research into immunoconjugate design is essential for an effective heroin vaccine.
More Related Videos
Related Concept Videos
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
01:22CNS Stimulants: Psychedelic Agents
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...